KREBSBIO.NS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 10, 2026
Report Source: 2026 2nd Quarter Report
Krebs Biochemicals and Industries Ltd. Stock Analysis KREBSBIO.NS
Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. The firm manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The firm has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.
Read More Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) Chart
Key Statistics of Krebs Biochemicals and Industries Ltd (KREBSBIO.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹56.00Volume
1777.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1.27BAvg. Volume
3078.36Dividend Yield
-Financial Metrics & Statements of Krebs Biochemicals and Industries Ltd (KREBSBIO.NS)
FAQ's for Krebs Biochemicals and Industries Ltd (KREBSBIO.NS)
- According to Musaffa’s Shariah screening methodology, Krebs Biochemicals and Industries Ltd (KREBSBIO.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.